These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21875223)

  • 21. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
    Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
    Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.
    Pickworth WB; Fant RV; Butschky MF; Henningfield JE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):450-6. PubMed ID: 8930145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist.
    Knott V; McIntosh J; Millar A; Fisher D; Villeneuve C; Ilivitsky V; Horn E
    Pharmacol Biochem Behav; 2006 Sep; 85(1):228-42. PubMed ID: 17023037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of transdermal nicotine on inspection time.
    Thompson JC; Wilby G; Stough C
    Hum Psychopharmacol; 2002 Apr; 17(3):157-61. PubMed ID: 12404693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilance.
    Gilbert DG; Dibb WD; Plath LC; Hiyane SG
    Psychophysiology; 2000 Sep; 37(5):583-95. PubMed ID: 11037035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light up and see: enhancement of the visual mismatch negativity (vMMN) by nicotine.
    Fisher DJ; Scott TL; Shah DK; Prise S; Thompson M; Knott VJ
    Brain Res; 2010 Feb; 1313():162-71. PubMed ID: 20006592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
    Sofuoglu M; Babb D; Hatsukami DK
    Nicotine Tob Res; 2003 Dec; 5(6):947-53. PubMed ID: 14668079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study.
    Hjalmarson A; Franzon M; Westin A; Wiklund O
    Arch Intern Med; 1994 Nov; 154(22):2567-72. PubMed ID: 7979853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions.
    Rigbi A; Yakir A; Sarner-Kanyas K; Pollak Y; Lerer B
    Pharmacogenomics J; 2011 Feb; 11(1):45-52. PubMed ID: 20231857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history.
    Hughes JR; Rose GL; Callas PW
    Alcohol Clin Exp Res; 2000 Nov; 24(11):1633-8. PubMed ID: 11104110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute nicotine administration in Alzheimer's disease: an exploratory EEG study.
    Knott V; Engeland C; Mohr E; Mahoney C; Ilivitsky V
    Neuropsychobiology; 2000; 41(4):210-20. PubMed ID: 10828731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of enhancing cholinergic neurotransmission by nicotine on EEG indices of inhibition in the human brain.
    Logemann HN; Böcker KB; Deschamps PK; Kemner C; Kenemans JL
    Pharmacol Biochem Behav; 2014 Jul; 122():89-96. PubMed ID: 24690513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers.
    Caldwell B; Burgess C; Crane J
    Nicotine Tob Res; 2010 Feb; 12(2):179-83. PubMed ID: 20064899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials.
    Knott V; Bosman M; Mahoney C; Ilivitsky V; Quirt K
    Pharmacol Biochem Behav; 1999 Jun; 63(2):253-61. PubMed ID: 10371654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers.
    Harakas P; Foulds J
    Psychopharmacology (Berl); 2002 May; 161(3):271-7. PubMed ID: 12021830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
    Poltavski DV; Petros T
    Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EEG differences between eyes-closed and eyes-open resting conditions.
    Barry RJ; Clarke AR; Johnstone SJ; Magee CA; Rushby JA
    Clin Neurophysiol; 2007 Dec; 118(12):2765-73. PubMed ID: 17911042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.